查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539812

2024 年粘膜给药装置全球市场报告

Transmucosal Drug Delivery Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

粘膜给药装置市场规模预计在未来几年将强劲成长。 2028年将以9.3%的年复合成长率（CAGR）成长至716.9亿美元。预测期内的预期增长是由智能给药系统的进步、慢性病患病率上升、对个性化医疗的日益重视、人口老龄化和医疗需求高以及医疗保健提供者和患者的认识推动的，这是由多种因素造成的。在此期间预计的主要趋势包括药物输送系统治疗应用的开发、满足个人化医疗需求的设备客製化、遵守监管核准和指南、渗透到新兴市场以及环境方面，其中包括温和设备的开发和创新配方技术。

粘膜给药装置市场的预期成长速度预计将由慢性病盛行率的增加所推动。慢性病是进展缓慢的长期疾病，需要持续的医疗管理来控制症状并预防併发症。导致慢性病增加的因素包括生活方式选择、老化、环境因素、医疗保健系统内的挑战以及都市化趋势。粘膜药物输送装置透过提供受控且有效的药物输送，在慢性病的治疗中发挥重要作用。这确保了持续的治疗水平，增强了症状控制，并提高了患者对治疗方法的依从性。例如，根据国际糖尿病联盟 (IDF) 2021 年 7 月的报告，全球约有 5.37 亿人患有糖尿病。患者数量正稳定增加，预计到2045年，约有7.83亿人将受到糖尿病的影响。这一显着增长凸显了慢性病盛行率的增加是粘膜给药装置市场成长的关键驱动力。

经粘膜给药装置领域的主要企业正在积极寻求创新解决方案，例如专有的经皮吸收贴片给药平台，该平台可改善药物吸收，提高患者依从性，并提供便利。这些平台持有各公司的专业技术透过皮肤输送药物，提供控制释放并优化治疗结果。例如，2024 年 1 月，美国生物技术公司 Starton Therapeutics Inc. 宣布推出 STARSILON，这是一种新型专有经皮吸收贴片递送平台。该平台专门设计用于长时间输送难以配製的活性药物成分（API），从而扩大经皮药物输送选择，并透过缓释机制提高治疗效果。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球粘膜给药装置市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球粘膜给药装置市场表现：规模与成长，2018-2023
  • 全球粘膜给药装置市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球粘膜给药装置市场：按类型、性能和预测，2018-2023、2023-2028、2033
  • 被动经皮给药
  • 主动经皮给药
  • 全球粘膜给药装置市场：依药物类型分類的表现与预测，2018-2023、2023-2028、2033
  • 含片
  • 口腔喷雾剂
  • 舌下膜和薄片
  • 凝胶
  • 药用糖果零食
  • 其他的
  • 全球粘膜给药装置市场：依适应症、性能及预测划分，2018-2023年、2023-2028年、2033年
  • 疼痛管理
  • 成瘾治疗
  • 荷尔蒙疗法
  • 其他的
  • 全球粘膜给药装置市场：依最终使用者、实际及预测，2018-2023、2023-2028、2033
  • 学术研究所
  • 製药和生物技术公司
  • 诊断实验室
  • 医院

第 7 章 区域/国家分析

  • 全球粘膜给药装置市场：按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球粘膜给药装置市场：依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 粘膜给药装置市场：竞争格局
  • 粘膜给药装置市场：公司简介
    • Johnson & Johnson
    • Bayer AG
    • Sanofi SA
    • Bristol-Myers Squibb Company
    • Abbott Laboratories

第31章 其他大型创新企业

  • Novartis AG
  • Becton Dickinson and Company
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • AptarGroup
  • Glenmark Pharmaceuticals Limited
  • Stevanato Group SpA
  • Lifevision Healthcare Private Limited
  • Noven Pharmaceuticals
  • SAVA Healthcare Limited
  • Antares Pharma Inc.
  • Kaizen Pharmaceuticals Pvt. Ltd.
  • Lucky Pharma Pvt. Ltd.
  • Maya Biotech Pvt. Ltd

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r19251

Transmucosal drug delivery devices are medical instruments designed to administer drugs through mucous membranes, such as those found in the mouth, nose, or rectum, allowing for rapid absorption into the bloodstream. These devices are particularly useful for delivering medications that are poorly absorbed by the gastrointestinal tract or require swift onset of action, such as pain relief or hormone therapy. Their primary function is to circumvent the digestive system, offering a direct and efficient route for drug delivery.

The two main categories of transmucosal drug delivery devices are passive transmucosal drug delivery and active transmucosal drug delivery. Passive transmucosal drug delivery involves the absorption of drugs through mucous membranes without external energy or active transport mechanisms. Various types of products include buccal tablets, oral sprays, sublingual films, wafers, gels, medicated confectionery, among others, used for treating conditions such as pain management, addiction, and hormonal therapies. End users include academic and research institutions, pharmaceutical and biotechnology firms, diagnostic laboratories, and hospitals.

The transmucosal drug delivery devices research report is one of a series of new reports from The Business Research Company that provides transmucosal drug delivery devices market statistics, including the transmucosal drug delivery devices industry's global market size, regional shares, competitors with a transmucosal drug delivery devices market share, detailed transmucosal drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the transmucosal drug delivery devices industry. This transmucosal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $46.16 billion in 2023 to $50.24 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth observed in the historical period can be attributed to several factors, the demand for rapid relief from angina, the effectiveness of sublingual delivery for swift absorption into the bloodstream, the preference for bypassing gastrointestinal degradation, advancements in the development of buccal tablets, and the necessity for non-invasive delivery of peptides and proteins.

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $71.69 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be attributed to several factors, including the advancement of smart drug delivery systems, a rise in the prevalence of chronic diseases, increasing emphasis on personalized medicine, a growing aging population with higher medication requirements, and heightened awareness among healthcare providers and patients. Key trends expected in this period include the expansion of therapeutic applications for drug delivery systems, customization of devices to meet the needs of personalized medicine, adherence to regulatory approvals and guidelines, penetration into emerging markets, development of eco-friendly devices, and innovation in formulation technologies.

The anticipated growth of the transmucosal drug delivery devices market is expected to be driven by the growing prevalence of chronic diseases. Chronic diseases are long-lasting conditions that progress slowly and require ongoing medical management to control symptoms and prevent complications. Factors contributing to the rise in chronic diseases include lifestyle choices, aging populations, environmental factors, challenges within healthcare systems, and urbanization trends. Transmucosal drug delivery devices play a crucial role in the management of chronic diseases by providing controlled and efficient delivery of medications. This ensures sustained therapeutic levels, enhances symptom management, and improves patient adherence to treatment regimens. For example, according to a July 2021 report from the International Diabetes Federation (IDF), approximately 537 million people worldwide were living with diabetes. The number of cases has been steadily increasing, with projections suggesting that by 2045, around 783 million people will have diabetes-an increase of 46%. This significant rise underscores how the increasing prevalence of chronic diseases is a key driver behind the growth of the transmucosal drug delivery devices market.

Leading companies in the transmucosal drug delivery devices sector are actively pursuing innovative solutions such as proprietary transdermal patch delivery platforms, which are designed to improve drug absorption, enhance patient compliance, and offer convenience. These platforms utilize specialized technologies owned by companies to administer medications through the skin, ensuring controlled release and optimized therapeutic outcomes. For example, in January 2024, Starton Therapeutics Inc., a US-based biotechnology firm, introduced STARSILON, a novel proprietary transdermal patch delivery platform. This platform is specifically designed to deliver difficult-to-formulate active pharmaceutical ingredients (APIs) over an extended period, thereby expanding the options for transdermal drug delivery and enhancing therapeutic efficacy through sustained release mechanisms.

In April 2023, Difgen Pharmaceuticals, an India-based pharmaceutical company, acquired Aveva Drug Delivery Services for an undisclosed sum. This strategic acquisition is intended to bolster Difgen Pharmaceuticals' drug delivery capabilities and incorporate advanced technologies into its pharmaceutical product portfolio. Aveva Drug Delivery Services, based in the US, specializes in manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

North America was the largest region in the transmucosal drug delivery devices market in 2023. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transmucosal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transmucosal drug delivery devices market consists of sales of sublingual sprays, nasal drops, rectal suppositories, and sublingual tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transmucosal Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transmucosal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transmucosal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transmucosal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Passive Transdermal Drug Delivery; Active Transdermal Drug Delivery
  • 2) By Drug Type: Buccal Tablets; Oral Sprays; Sublingual Films And Wafers; Gels; Medicated Confectionery; Other Drug Types
  • 3) By Indication: Pain Management; Addiction Treatment; Hormonal Therapies; Others Indications
  • 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Hospitals
  • Companies Mentioned: Johnson & Johnson; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transmucosal Drug Delivery Devices Market Characteristics

3. Transmucosal Drug Delivery Devices Market Trends And Strategies

4. Transmucosal Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Transmucosal Drug Delivery Devices Market Size and Growth

  • 5.1. Global Transmucosal Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Transmucosal Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Transmucosal Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Transmucosal Drug Delivery Devices Market Segmentation

  • 6.1. Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Passive Transdermal Drug Delivery
  • Active Transdermal Drug Delivery
  • 6.2. Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Buccal Tablets
  • Oral Sprays
  • Sublingual Films And Wafers
  • Gels
  • Medicated Confectionery
  • Other Drug Types
  • 6.3. Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Addiction Treatment
  • Hormonal Therapies
  • Others Indications
  • 6.4. Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals

7. Transmucosal Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Transmucosal Drug Delivery Devices Market

  • 8.1. Asia-Pacific Transmucosal Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Transmucosal Drug Delivery Devices Market

  • 9.1. China Transmucosal Drug Delivery Devices Market Overview
  • 9.2. China Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Transmucosal Drug Delivery Devices Market

  • 10.1. India Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Transmucosal Drug Delivery Devices Market

  • 11.1. Japan Transmucosal Drug Delivery Devices Market Overview
  • 11.2. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Transmucosal Drug Delivery Devices Market

  • 12.1. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Transmucosal Drug Delivery Devices Market

  • 13.1. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Transmucosal Drug Delivery Devices Market

  • 14.1. South Korea Transmucosal Drug Delivery Devices Market Overview
  • 14.2. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Transmucosal Drug Delivery Devices Market

  • 15.1. Western Europe Transmucosal Drug Delivery Devices Market Overview
  • 15.2. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Transmucosal Drug Delivery Devices Market

  • 16.1. UK Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Transmucosal Drug Delivery Devices Market

  • 17.1. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Transmucosal Drug Delivery Devices Market

  • 18.1. France Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Transmucosal Drug Delivery Devices Market

  • 19.1. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Transmucosal Drug Delivery Devices Market

  • 20.1. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Transmucosal Drug Delivery Devices Market

  • 21.1. Eastern Europe Transmucosal Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Transmucosal Drug Delivery Devices Market

  • 22.1. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Transmucosal Drug Delivery Devices Market

  • 23.1. North America Transmucosal Drug Delivery Devices Market Overview
  • 23.2. North America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Transmucosal Drug Delivery Devices Market

  • 24.1. USA Transmucosal Drug Delivery Devices Market Overview
  • 24.2. USA Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Transmucosal Drug Delivery Devices Market

  • 25.1. Canada Transmucosal Drug Delivery Devices Market Overview
  • 25.2. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Transmucosal Drug Delivery Devices Market

  • 26.1. South America Transmucosal Drug Delivery Devices Market Overview
  • 26.2. South America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Transmucosal Drug Delivery Devices Market

  • 27.1. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Transmucosal Drug Delivery Devices Market

  • 28.1. Middle East Transmucosal Drug Delivery Devices Market Overview
  • 28.2. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Transmucosal Drug Delivery Devices Market

  • 29.1. Africa Transmucosal Drug Delivery Devices Market Overview
  • 29.2. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Transmucosal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Transmucosal Drug Delivery Devices Market Competitive Landscape
  • 30.2. Transmucosal Drug Delivery Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bristol-Myers Squibb Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Transmucosal Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Viatris Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Catalent Inc.
  • 31.6. AptarGroup
  • 31.7. Glenmark Pharmaceuticals Limited
  • 31.8. Stevanato Group S.p.A
  • 31.9. Lifevision Healthcare Private Limited
  • 31.10. Noven Pharmaceuticals
  • 31.11. SAVA Healthcare Limited
  • 31.12. Antares Pharma Inc.
  • 31.13. Kaizen Pharmaceuticals Pvt. Ltd.
  • 31.14. Lucky Pharma Pvt. Ltd.
  • 31.15. Maya Biotech Pvt. Ltd

32. Global Transmucosal Drug Delivery Devices Market Competitive Benchmarking

33. Global Transmucosal Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Transmucosal Drug Delivery Devices Market

35. Transmucosal Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Transmucosal Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Transmucosal Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Transmucosal Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer